Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GFS vs GSK✓SelectedUSD · GSKGFS vs GSK performance historyLatest closeAs of-4.94%11/16
Stock and ETF performance explorer

GFS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-14.7%
GSK return
+50.7%
Excess return
-65.4%
Maximum drawdown
-61.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.9%-0.1%-4.9%-4.9%
7D-2.7%-1.3%-1.4%-2.6%
30D-15.6%+2.7%-18.3%-15.9%
3M-27.6%+2.7%-30.3%-28.0%
6M-44.3%+3.3%-47.6%-44.9%
YTD+13.3%+6.5%+6.9%+11.2%
1Y+19.7%+10.7%+9.1%+16.7%
3Y-29.9%+64.4%-94.2%-37.3%
5Y-35.8%+46.7%-82.5%-41.3%
All-14.7%+50.7%-65.4%-22.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling